Reference : Penicillin-binding proteins: evergreen drug targets.
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
Penicillin-binding proteins: evergreen drug targets.
Frère, Jean-Marie [Université de Liège - ULiège > > >]
Page, Malcolm G. P. [> >]
Current Opinion in Pharmacology
Yes (verified by ORBi)
United Kingdom
[en] Anti-Bacterial Agents/pharmacology ; Penicillin Resistance/physiology ; Penicillin-Binding Proteins/antagonists & inhibitors/chemistry/metabolism ; Protein Conformation ; beta-Lactams/pharmacology
[en] The penicillin-binding proteins (PBPs) are well known targets for the beta-lactam antibiotics. They continue to be a focus of interest for pharmaceutical design, as exemplified by the number of new agents under clinical investigation as well as novel experimental molecules. Considerable advances have been made in understanding the structure and function of this family of enzymes, through high-resolution structural studies and mechanistic studies in solution. These studies have thrown light on role of the high molecular mass PBPs in mediating beta-lactam resistance, although much work remains to be done to enable a full description of the mechanisms by which these proteins modulate their sensitivity towards beta-lactams while retaining their essential activity in cell wall biosynthesis.
Copyright (c) 2014 Elsevier Ltd. All rights reserved.

File(s) associated to this reference

Fulltext file(s):

Restricted access
Frere_2014.pdfPublisher postprint507.06 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.